Take control of your vision health today !

Our cutting-edge AI technology can help you evaluate, monitor and act on your risk of Age-related Macular Degeneration

Coming soon

Orusight is a software application intended to educate patients about their potential risk of vision loss resulting from advanced Age-related Macular Degeneration (AMD). It is tailored to personalize and enhance patient adherence to a Mediterranean diet, fostering a proactive approach to vision health management.

Access our Beta Program

Innovating Healthy Aging

Vision, Challenges, and Solutions


Our healthcare system tends to be more reactive than preventive, often addressing issues after they arise. Recognizing the importance of proactive measures, RetiNov strives to offer AI-based solutions that empower patients in their pursuit of healthy aging, emphasizing prevention as a key component of their approach.



We have developed Orusight, a digital platform integrating proprietary AI algorithms to predict patients risk of advanced AMD at 5 years with a 93% precision, based on a fundus image, blood pressure and a lifestyle questionnaire. Orusight also provides patients with a tailored follow-up (personalized lifestyle recommendations, monitoring of omega-3 retinal levels for high-risk patients) to help them act on their risk over time and preserve their vision longer.



Two-thirds of people suffering from AMD are not diagnosed until it's too late. This is mainly due to a lack of awareness of this disease and its risk factors but also to a lack of tools enabling patients to monitor their risk of advanced AMD and act on it over time. Both these factors generate a huge cost for the healthcare system, reaching $100B per year for North America.



Empowering Visionary Healthcare

Discover RetiNov's visionary approach through Orusight, our cutting-edge platform, our mission to educate and provide predictive tools for AMD, and our core values of integrity and innovation in patient empowerment.


RetiNov has developed Orusight, a digital platform based on Artificial Intelligence to predict the risk of progressing to the advanced stages of age-related macular degeneration (AMD) and offer patients personalized care, enabling them to preserve their vision for longer.


To offer patients equitable and easier access to popularised and scientifically verified information for a better understanding of AMD while providing them with predictive tools to help them monitor their risk over time.


We strive to respect the principles that define our DNA

  • Diversity and inclusion

    We aim to build a multicultural team of unique individuals who contribute to creating a safer, more harmonious and dynamic working environment

  • Transparency and integrity

    RetiNov is driven by the values of integrity and honesty, which are essential to forging lasting bonds of solidarity within our team

  • Creativity and innovation

    Every day, we dedicate ourselves to providing state-of-the-art technologies that support patients in their journey toward active and healthy aging

Proudly supported by